Welcome to our dedicated page for Delek Us Hldgs SEC filings (Ticker: DK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Delek US Holdings, Inc. (NYSE: DK) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, with AI-powered tools to help interpret them. Delek US uses Form 8-K filings to furnish quarterly earnings releases, dividend announcements, investor presentations, and earnings call slides, giving investors a structured view of its financial condition and strategic messaging.
Through Item 2.02 of Form 8-K, Delek US reports results of operations and financial condition, including net income or loss, Adjusted net income, Adjusted EBITDA, and segment-level performance for refining and logistics. These filings often reference non-GAAP measures such as refining margin, adjusted refining margin, refining production margin, and net debt, along with reconciliations to GAAP metrics described in accompanying tables.
Item 7.01 Regulation FD disclosures in Delek US 8-Ks typically include earnings call slides and investor presentations. The company notes that these materials are furnished, not filed, and may be used in presentations to existing and prospective investors. Item 8.01 is used for other events, such as Board-approved quarterly dividends per share, with details on record and payment dates.
On this page, Stock Titan’s AI summarizes the key points from each filing so users can quickly understand what changed in Delek US’s business, capital allocation, and midstream relationship with Delek Logistics Partners, LP. Real-time updates from EDGAR ensure that new 8-Ks and other forms appear promptly, while AI-generated highlights help clarify complex sections, such as non-GAAP definitions and regulatory language, without replacing the need to review the full original documents.
Delek US Holdings, Inc. director William J. Finnerty reported an open-market sale of 5,000 shares of Common Stock at $47.50 per share. The transaction was made pursuant to a Rule 10b5-1 trading plan. After this sale, he directly holds 36,369 shares.
Joseph Finnerty filed a Form 144 reporting dispositions of Common stock. The filing lists sales in March 2026: a $227,500 sale of 5,000 shares on 03/18/2026 and a $230,508 sale of 5,392 shares on 03/04/2026. The record also lists 5,000 Restricted Stock Units dated 06/10/2017 as the securities to be sold.
Delek US Holdings Inc: The Vanguard Group filed Amendment No. 10 to Schedule 13G/A reporting Amount beneficially owned: 0 and Percent of class: 0% in the issuer's Common Stock.
The filing states Vanguard completed an internal realignment on January 12, 2026 and, in accordance with SEC Release No. 34-39538, certain subsidiaries will report beneficial ownership separately going forward.
Delek US Holdings director Zohar Shlomo sold 7,343 shares of common stock in an open-market transaction at $46.00 per share. The sale occurred on March 19, 2026 and was executed under a pre-arranged Rule 10b5-1 trading plan. After this transaction, Shlomo directly holds 6,646 Delek US shares.
Director Ezra Uzi Yemin reported open-market sales totaling 55,356 shares of Delek US Holdings, Inc. common stock on March 18, 2026. The trades were executed at weighted average prices of $43.73 and $44.20 per share, across price ranges from $43.07 to $44.48.
After these sales, Yemin holds 228,419 shares directly and 569,651 shares indirectly through Yemin Investments, LP. The transactions were made under a pre-arranged Rule 10b5-1 trading plan, which indicates the timing was scheduled in advance rather than opportunistic.
Delek US Holdings director William J. Finnerty sold 5,000 shares of Common Stock in an open-market transaction at $45.50 per share. After the sale, he directly holds 41,369 shares. The transaction was executed under a Rule 10b5-1 trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
DK filed a Form 144 reporting proposed sales of Common Stock through Fidelity Brokerage Services LLC on 03/19/2026. The filing lists recent open-market dispositions by Shlomo Zohar: 03/04/2026 7,343 shares for $315,749.00, 03/05/2026 22,029 shares for $987,633.50, and 03/09/2026 5,000 shares for $207,325.00.
The form also lists previously vested restricted stock awards with vesting dates and share counts (examples include 873 shares vested 06/10/2020 and 1,562 shares vested 12/10/2020), provided as background on the securities involved.
Ezra Uzi Yemin and affiliated Yemin Investments LP reported sales of Common stock. The filing shows Yemin Investments LP sold 66,511 shares on 03/04/2026 and Ezra Uzi Yemin sold 18,139 shares on 03/04/2026. The transactions are reported on a Form 144 as transfers of previously acquired compensation shares.
DK reports insider sales of Common Stock by Yemin-related holders. The filing shows Yemin Investments LP sold 66,511 shares and Ezra Uzi Yemin sold 18,139 shares, both reported as sold on 03/04/2026. The transactions are reported on Form 144 and reflect dispositions of issuer common stock.
DK filing a Section 144 notice indicating 5,000 common shares are to be sold. The filing lists the broker Morgan Stanley Smith Barney LLC and identifies the securities as restricted stock units dated 03/10/2019.
It also discloses a recent sale of 5,392 shares on 03/04/2026 for $230,508.00.